Cite
HARVARD Citation
Limsuwanachot, N. et al. (2017). Clinical and hematological relevance of JAK2 V617F and CALR mutations in BCR-ABL-negative ET patients. Hematology. 22 (10), pp. 599-606. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Limsuwanachot, N. et al. (2017). Clinical and hematological relevance of JAK2 V617F and CALR mutations in BCR-ABL-negative ET patients. Hematology. 22 (10), pp. 599-606. [Online].